Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders
The Journal of Clinical Psychiatry · 2024
DOI: 10.4088/jcp.24f15363 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Psychiatry, 2024. Verfasst von Chittaranjan Andrade. Beteiligte Einrichtung: Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (candrade@psyc…. Hauptthemen laut MEDLINE: Antipsychotic Agents, Schizophrenia, Psychotic Disorders. Die Arbeit wurde bisher 6-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Psychopharmacology and Neurotoxicology, National Institute of Mental Health and Neurosciences, Bangalore, India (candrade@psychiatrist.com).
Zitieren
APA
Andrade, C. (2024). Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.24f15363
Vancouver
Andrade C. Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders. The Journal of Clinical Psychiatry. 2024. doi:10.4088/jcp.24f15363
BibTeX
@article{Andrade2024,
author = {Andrade, Chittaranjan},
title = {Antipsychotic Medication Continuation vs Taper and Discontinuation in Patients With Schizophrenia and Other Nonaffective Psychotic Disorders},
journal = {The Journal of Clinical Psychiatry},
year = {2024},
doi = {10.4088/jcp.24f15363}
}
EUVIMED